COMMUNIQUÉS West-GlobeNewswire

Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care Zika/Chikungunya/Dengue Tests and Micro Readers
07/03/2019
MEDFORD, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that it will be awarded a conditional Long [...]
La Jolla Pharmaceutical Company to Present at the 39th Annual Cowen Healthcare Conference
07/03/2019
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
ChromaDex Corporation Reports 2018 Financial Results
07/03/2019
- Full Year 2018 Net Revenues Increased by 49% to $31.6 Million and Fourth Quarter 2018 Net Revenues Increased by 20% to $9.1 Million - Fourth Quarter 2018 Highlights vs. Fourth Quarter 2017 Entered into a global [...]
T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
07/03/2019
Secured 14 New Instrument Contracts in the Fourth Quarter and 39 total New Instrument Contracts in 2018 that are expected to drive growth in Recurring Test Revenue Confirms Guidance of a Doubling of Revenue in 2019; [...]
Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
07/03/2019
- Clinical trial results expected for AB-506, a potent capsid inhibitor, and AB-729, a subcutaneously administered RNAi agent targeting HBsAg - Ongoing analyses of AB-452, a novel orally-available RNA destabilizer, with [...]
Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
07/03/2019
Acer continues to progress toward goals of commercializing EDSIVO™ and advancing pipeline NEWTON, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the [...]
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019
07/03/2019
RANCHO CUCAMONGA, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2018 ended December 31, 2018, after [...]
Verrica Reports Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
WEST CHESTER, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that [...]
Celldex Provides Corporate Update and Reports Full Year 2018 Results
07/03/2019
HAMPTON, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December 31, 2018. The Company will host [...]
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
07/03/2019
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the fourth [...]
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018
07/03/2019
CAMBRIDGE, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Immunomedics Appoints Barbara G. Duncan to Board of Directors
07/03/2019
MORRIS PLAINS, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Align Technology Announces Distribution Agreement With Benco Dental for iTero Element® Intraoral Scanners
07/03/2019
SAN JOSE, Calif. and PITTSTON, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today announced a distribution agreement with Benco Dental, the largest privately-owned dental distributor in [...]
OncoMed Announces Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
REDWOOD CITY, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]
Administrative Law Judge Determines 3Shape Infringes Three Align Patents; Initial Determination Declines to Find Section 337 Violation
07/03/2019
Align Will Seek Commission Review of ALJ’s Initial Determination ALJ Declines to Address Two Other Align Patents because of Delay Resulting from U.S. Government Shutdown SAN JOSE, Calif., March 07, 2019 (GLOBE NEWSWIRE [...]
Protech Home Medical Announces Closing of $15 Million Bought Deal Offering
07/03/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CINCINNATI, March 07, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the " Company ") (TSXV: PTQ) is pleased to [...]
Aleafia Health to Graduate to Toronto Stock Exchange
07/03/2019
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) announced today that the Company has received conditional approval from the [...]
RavenQuest Announces Non-Brokered Private Placement
07/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
07/03/2019
Orphazyme A/S Company announcement No. 08/2019 Company Registration No. 32266355 Copenhagen, Denmark, March 7, 2019 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), [...]

Pages